Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,032 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T, Takazono T, Hosogaya N, Ogura E, Fujiwara M, Miyauchi H, Ajisawa Y, Iwata S, Watanabe H, Honda K, Kitanishi Y, Hara K, Mukae H. Komeda T, et al. Among authors: fujiwara m. Clin Infect Dis. 2021 Jun 1;72(11):e859-e867. doi: 10.1093/cid/ciaa1622. Clin Infect Dis. 2021. PMID: 33103200
Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T, Takazono T, Hosogaya N, Miyazaki T, Ogura E, Iwata S, Miyauchi H, Honda K, Fujiwara M, Ajisawa Y, Watanabe H, Kitanishi Y, Hara K, Mukae H. Komeda T, et al. Among authors: fujiwara m. Clin Infect Dis. 2021 Sep 7;73(5):e1181-e1190. doi: 10.1093/cid/ciaa1870. Clin Infect Dis. 2021. PMID: 33354728 Free PMC article.
Comparison of the incidence of bleeding between baloxavir marboxil and other anti-influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment-based health insurance claims database in Japan.
Hara A, Hara K, Komeda T, Ogura E, Miyazawa S, Kobayashi C, Fujiwara M, Yoshida M, Urushihara H. Hara A, et al. Among authors: fujiwara m. Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):623-631. doi: 10.1002/pds.5392. Epub 2021 Dec 23. Pharmacoepidemiol Drug Saf. 2022. PMID: 34881477 Free PMC article.
Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database.
Miyazawa S, Takazono T, Hosogaya N, Yamamoto K, Watanabe H, Fujiwara M, Fujita S, Mukae H. Miyazawa S, et al. Among authors: fujiwara m. Clin Infect Dis. 2022 Sep 29;75(6):927-935. doi: 10.1093/cid/ciac068. Clin Infect Dis. 2022. PMID: 35100617 Free PMC article.
Efficacy and safety of guanfacine extended-release in Japanese adults with attention-deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study.
Naya N, Sakai C, Okutsu D, Kiguchi R, Fujiwara M, Tsuji T, Iwanami A. Naya N, et al. Among authors: fujiwara m. Neuropsychopharmacol Rep. 2021 Mar;41(1):26-39. doi: 10.1002/npr2.12152. Epub 2020 Dec 10. Neuropsychopharmacol Rep. 2021. PMID: 33305542 Free PMC article. Clinical Trial.
3,032 results